Because there is potential that Avinza could harm a developing baby, it is important to tell your doctor if you are pregnant or planning to become pregnant while taking Avinza. Avinza is a pregnancy Category C medication. This means that either: 1) animal studies have shown the medication to pose a risk to the fetus, but sufficient human studies have not been conducted, or 2) no studies of the medication's impact on a fetus have been conducted in animals or humans.
Research suggests that taking Avinza while breastfeeding poses minimal risk to the baby. If you are breastfeeding while taking Avinza, watch for the following signs that your baby is being exposed to too much Avinza through breast milk: baby does not nurse every two to three hours, sleeps more than four hours at a time, shows severe sleepiness, has difficulty feeding or breathing or is limp. If any of these symptoms is observed, take your infant to an emergency room for immediate care.
Continue Learning about Opiate Agonists
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.